We are live on ! Find out more
BG

Bellevue Group Portfolio holdings

AUM $4.2B
1-Year Est. Return 54.85%
This Fund
S&P 500
This Quarter Est. Return
+4.43%
1 Year Est. Return
+54.85%
3 Year Est. Return
+140.3%
5 Year Est. Return
+171.01%
10 Year Est. Return
+915.55%
AUM
$956M
AUM Growth
+$110M
Cap. Flow
+$88M
Cap. Flow %
9.21%
Top 10 Hldgs %
34.18%
Holding
136
New
4
Increased
63
Reduced
26
Closed
5

Top Buys

Rank Stock Value
1
ILMN icon
Illumina
ILMN
+$10.5M
2
ALGN icon
Align Technology
ALGN
+$9.68M
3
CELG
Celgene Corp
CELG
+$9.59M
4
ELV icon
Elevance Health
ELV
+$9.1M
5
COR icon
Cencora
COR
+$7.21M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$7.35M
2
CI icon
Cigna
CI
+$4.96M
3
BCR
CR Bard Inc.
BCR
+$4.65M
4
CNC icon
Centene
CNC
+$4.38M
5
ALKS icon
Alkermes
ALKS
+$4.36M

Sector Composition

Rank Sector Weight
1 Healthcare 94.19%
2 Financials 0.94%
3 Industrials 0.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CELG
1
DELISTED
Celgene Corp
CELG
$48.5M 5.07%
332,369
+70,377
+27% +$9.59M
AMGN icon
2
Amgen
AMGN
$198B
$37M 3.87%
198,645
+34,917
+21% +$6.19M
ALGN icon
3
Align Technology
ALGN
$12.7B
$35.9M 3.75%
192,746
+56,546
+42% +$9.68M
GILD icon
4
Gilead Sciences
GILD
$167B
$32.6M 3.41%
402,541
+90,738
+29% +$6.94M
ILMN icon
5
Illumina
ILMN
$28.2B
$32.6M 3.41%
168,104
+56,602
+51% +$10.5M
ELV icon
6
Elevance Health
ELV
$80.9B
$32.5M 3.4%
171,143
+47,796
+39% +$9.1M
ISRG icon
7
Intuitive Surgical
ISRG
$122B
$31.8M 3.32%
273,393
+60,039
+28% +$6.54M
ABT icon
8
Abbott
ABT
$175B
$26.8M 2.81%
503,000
+60,000
+14% +$3.01M
UNH icon
9
UnitedHealth
UNH
$387B
$26.7M 2.79%
136,270
+7,230
+6% +$1.4M
EW icon
10
Edwards Lifesciences
EW
$49.4B
$22.5M 2.35%
617,580
+47,880
+8% +$1.83M
LLY icon
11
Eli Lilly
LLY
$1.05T
$20.6M 2.16%
241,262
+60,189
+33% +$4.94M
BSX icon
12
Boston Scientific
BSX
$65.4B
$20.3M 2.12%
696,000
+68,000
+11% +$1.88M
WBA
13
DELISTED
Walgreens Boots Alliance
WBA
$20.2M 2.12%
262,060
+76,188
+41% +$6.11M
BIIB icon
14
Biogen
BIIB
$30.4B
$18.4M 1.93%
58,900
-2,600
-4% -$770K
INCY icon
15
Incyte
INCY
$23.4B
$17.1M 1.79%
146,366
+22,954
+19% +$2.9M
MDT icon
16
Medtronic
MDT
$106B
$16.9M 1.77%
217,000
-88,500
-29% -$7.35M
JAZZ icon
17
Jazz Pharmaceuticals
JAZZ
$15.5B
$16.9M 1.76%
115,252
+15,049
+15% +$2.28M
COR icon
18
Cencora
COR
$59.9B
$16.4M 1.71%
197,991
+84,933
+75% +$7.21M
ABMD
19
DELISTED
Abiomed Inc
ABMD
$14.3M 1.5%
85,110
+1,140
+1% +$172K
WMGI
20
DELISTED
Wright Medical Group Inc
WMGI
$14M 1.47%
541,801
+205,746
+61% +$5.67M
DHR icon
21
Danaher
DHR
$144B
$13.6M 1.42%
179,126
+17,822
+11% +$1.32M
BAX icon
22
Baxter International
BAX
$11.7B
$13.6M 1.42%
216,000
+10,000
+5% +$618K
REGN icon
23
Regeneron Pharmaceuticals
REGN
$70.9B
$13.5M 1.41%
30,200
+2,100
+7% +$999K
IONS icon
24
Ionis Pharmaceuticals
IONS
$8.99B
$13.5M 1.41%
265,706
+41,144
+18% +$2.16M
HOLX
25
DELISTED
Hologic
HOLX
$13.3M 1.39%
363,101
+89,678
+33% +$3.62M
1
2 3 4 5

Similar funds

WSFS
Wilmington Savings Fund Society Wilmington, Delaware $4.2B AUM 18.37% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $4.22B AUM 21.28% 1-Year Est. Return
HIP
HUB Investment Partners Austin, Texas $4.18B AUM 24.76% 1-Year Est. Return
DT
DV Trading Chicago, Illinois $4.22B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.23B AUM 20.9% 1-Year Est. Return
BT
Banque Transatlantique Paris, France $4.17B AUM 28.5% 1-Year Est. Return
NCM
Nearwater Capital Markets Dublin 4, Dublin, Ireland $4.24B AUM 66.03% 1-Year Est. Return
MSU
Mizuho Securities USA New York $4.24B AUM 23.1% 1-Year Est. Return

Bellevue Group's Q3 2017 Portfolio in Review

As of Q3 2017, Bellevue Group held 136 positions worth $956M, up 13% from $846M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Bellevue Group deployed $88M of net new capital in Q3 2017, opening 4 new positions and adding to 63 existing holdings. Its largest new stake was Henry Schein: 48,450 shares worth $3.12M.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 93% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Medtronic, an estimated $7.35M trimmed.

  • Bellevue Group's largest Q3 2017 buy was Henry Schein: 48,450 shares worth $3.12M.
  • Bellevue Group added most to Illumina in Q3 2017, an estimated $10.5M increase.
  • Bellevue Group's biggest Q3 2017 reduction was Medtronic, cutting an estimated $7.35M.
  • Bellevue Group fully exited China Biologic Products Holdings, Inc. in Q3 2017, selling an estimated $4.1M.
  • Bellevue Group's ten largest holdings make up 34% of its $956M portfolio in Q3 2017.
  • Bellevue Group opened 4 new positions and closed 5 in Q3 2017.
  • Bellevue Group's portfolio value rose 13% quarter-over-quarter to $956M.

Based on Bellevue Group's 13F filing for Q3 2017, filed 13 Nov 2017.